Chondrogenic Potential of Umbilical Cord-Derived Mesenchymal Stromal Cells: Insights and Innovations

Abstract

Background: The advent of tissue engineering and regenerative medicine has introduced innovative approaches to treating degenerative and traumatic injuries, particularly in cartilage, a tissue with limited self-repair capabilities. Among the various stem cell sources, umbilical cord-derived mesenchymal stromal cells (UC-MSCs) have garnered significant interest due to their non-invasive collection, minimal ethical concerns, and robust regenerative potential, particularly in cartilage regeneration.

Methods: A comprehensive literature review was conducted using multiple databases, including PubMed, Scopus, Web of Science, and Google Scholar. Search terms focused on "umbilical cordderived mesenchymal stromal cells," "chondrogenesis," "cartilage regeneration," and related topics. Studies published in the past two decades were included, with selection criteria emphasizing methodological rigor and relevance to UC-MSC chondrogenesis. The review synthesizes findings from various sources to provide a thorough analysis of the potential of UC-MSCs in cartilage tissue engineering.

Results: UC-MSCs exhibit significant chondrogenic potential, supported by their ability to differentiate into chondrocytes under specific conditions. Recent advancements include the development of biomaterial scaffolds and the application of genetic engineering techniques, such as CRISPR/Cas9, to enhance chondrogenic differentiation. Despite these advancements, challenges remain in standardizing cell isolation techniques, scaling up production for clinical use, and ensuring the long-term functionality of regenerated cartilage.

Conclusion: UC-MSCs offer a promising solution for cartilage regeneration in the field of regenerative medicine. Ongoing research is focused on overcoming current challenges through the use of advanced technologies, including bioreactors and gene editing. Collaborative efforts among researchers, clinicians, and bioengineers are essential to translating the potential of UC-MSCs into effective clinical therapies, which could significantly advance tissue regeneration and therapeutic innovation.

Keywords: Chondrogenesis; Mesenchymal stromal cells; Regenerative medicine; Tissue engineering; Umbilical cord.

Fig. 1

Proliferative potential of UC-MSCs to bone and cartilage tissue. A Empty sponge implanted in mice. B Undifferentiated UCB-MSCs cultured in collagen sponges for 24 h before implantation. C UCB-MSCs cultured in collagen sponges in the absence of growth factors for 14 days before implantation. D UCB-MSCs cultured in the presence of BMP-2 and TGF-β1 for 14 days before implantation. (Control) Healthy human articular cartilage and human bone. The scale bar corresponds to 100 μm. The global aspect of the sponge construct, at lower magnification, is presented in the inset of the left images (A–D). Adapted from Zhang et al.[12]

Fig. 2

Workflow of application of UC-MSCs for clinical application